ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $7,169,000 | -18.7% | 1,460,000 | -12.6% | 1.34% | -8.6% |
Q2 2021 | $8,821,000 | +10.0% | 1,670,600 | 0.0% | 1.46% | +24.4% |
Q1 2021 | $8,019,000 | +24.5% | 1,670,600 | +12.3% | 1.18% | +40.1% |
Q4 2020 | $6,442,000 | +5.1% | 1,487,800 | 0.0% | 0.84% | -29.9% |
Q3 2020 | $6,130,000 | +149.4% | 1,487,800 | +55.0% | 1.20% | +141.7% |
Q2 2020 | $2,458,000 | -51.5% | 960,000 | +231.0% | 0.50% | -76.6% |
Q2 2017 | $5,072,000 | -0.1% | 290,000 | 0.0% | 2.12% | -16.1% |
Q1 2017 | $5,075,000 | +5.4% | 290,000 | +1.8% | 2.53% | -11.0% |
Q4 2016 | $4,817,000 | +17.4% | 285,000 | +14.0% | 2.84% | +32.2% |
Q3 2016 | $4,103,000 | -9.7% | 250,000 | -16.7% | 2.15% | -29.2% |
Q2 2016 | $4,542,000 | -25.1% | 300,000 | -6.2% | 3.03% | -19.8% |
Q1 2016 | $6,064,000 | +12.7% | 320,000 | +68.4% | 3.78% | +68.1% |
Q4 2015 | $5,380,000 | +93.9% | 190,000 | +14.7% | 2.25% | +64.8% |
Q3 2015 | $2,774,000 | -29.5% | 165,700 | +10.5% | 1.36% | -12.8% |
Q2 2015 | $3,933,000 | -11.8% | 150,000 | -41.2% | 1.56% | -24.4% |
Q1 2015 | $4,460,000 | – | 255,000 | – | 2.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 1,423,578 | $8,826,000 | 6.08% |
Healthcare Value Capital, LLC | 200,000 | $1,240,000 | 2.33% |
ARMISTICE CAPITAL, LLC | 2,700,000 | $16,740,000 | 1.06% |
DELTEC ASSET MANAGEMENT LLC | 550,836 | $3,415,000 | 0.75% |
Broadfin Capital, LLC | 441,088 | $2,735,000 | 0.60% |
Kerrisdale Advisers, LLC | 229,347 | $1,422,000 | 0.51% |
Worth Venture Partners, LLC | 87,908 | $545,000 | 0.30% |
Mosaic Family Wealth, LLC | 91,314 | $566,000 | 0.24% |
EMERALD ADVISERS, LLC | 700,176 | $4,341,000 | 0.17% |
EMERALD MUTUAL FUND ADVISERS TRUST | 616,664 | $3,823,000 | 0.15% |